News
Recent news on knowledge and technology transfer
The Pocketknife Transfer by SPRIND
November 28, 2023
SPRIND presents the pocketknife transfer for start-up teams at universities and research institutions. It offers various tools with which the teams can prepare for discussions and negotiations on the evaluation and protection of intellectual property in the context of their spin-off. For example, the IP Wahl-O-Meter is designed to help them familiarize with different types of application models. The IP scorecard is designed to support them in IP evaluation and a database with model contracts for different IP transfer scenarios will serve as a reference point for participation agreements.
Helmholtz Enterprise Alumus Priavoid receives approval for a Phase II study of its drug candidate to combat Alzheimer's disease
November 28, 2023
The drug named PRI-002 has received approval for a Phase II trial from the European Medicines Agency (EMA). The study, called PRImus-AD, is being conducted by Priavoid, a Helmholtz Enterprise Alumus of Forschungszentrum Jülich (FZJ) and PRInnovation and it is funded by SPRIND. PRI-002 dissolves neurotoxic aggregates without immune system involvement. The Phase II trial aims to demonstrate efficacy in early Alzheimer's disease. Results are expected for 2026.
© SPRIND (f.l.t.r. Prof. Dr. Dieter Willbold, Dr. Dagmar Jürgens, Alexander Brener, Philipp Bürling)
Helmholtz Enterprise spin-off Marmorkrebs Bioproducts from DKFZ wins "German Food Startup Award"
November 25, 2023
On November 25, the Helmholtz Enterprise-funded spin-off Marmorkrebs Bioproducts from the German Cancer Research Center (DKFZ) won the "German Food Startup Award" at the innovate! Convention in Osnabrück. In the finale of a pitch competition, the team, consisting of Dr Vitor Carneiro, Prof Dr Frank Lyko, Dr Sina Tönges and Dr Ranja Andriantsoa, prevailed against their competitors.
The Marmorkrebs Bioproducts team at the convention (left to right: Dr. Ranja Andriantsoa, Dr. Vitor Carneiro, Dr. Sina Tönges, Prof. Dr. Frank Lyko)
Venture Capital Fund Sustainable & Invest - Investment in Cybersecurity at CISPA
October 24, 2023
For the first time, seven startups from the Incubator of the CISPA - Helmholtz Center for Information Security applied for funding from the CISPA Venture Capital Fund during a Pitch Day. CISPA emphasizes that investments should not only aim for financial returns, but also for sustainable benefit to society. Cybersecurity in particular is crucial for this in an increasingly connected world.
Peter Memminger, Managing Director of Sustainable & Invest GmbH gives the following outlook after the event: "We will discuss our impressions and then seek talks with the particularly promising startups. This is about a long and hopefully successful journey together, where both sides need to feel comfortable with their partner. To that end, the Pitch Day was an important first step, followed by getting to know each other in more detail and due diligence."
The goal of the CISPA ecosystem is to create a strong community of research, startups and investors in the fields of cybersecurity and AI, to which the venture capital fund represents a further important building block.
© CISPA | ltr. Peter Memminger (Managing Director of Sustainable & Invest GmbH,), Max Wolf (Head of Startups & Entrepreneurship at CISPA)
Contacts
Andreas Bergner
Head of Transfer and Innovation
Helmholtz Head Office
Julian Alexandrakis
Program Manager Transfer and Innovation